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Abstract
Hematologic cancers comprise an aggregate of several different cancers, such as leukemia,
lymphoma, and multiple myeloma. There are more than 100,000 new cases of these hematologic
cancers in the United States annually, and more than 50,000 children and adults die from these
cancers.1,2
Hematologic cancers affect the body’s blood, bone marrow, and lymphatic system, leaving these
patients more susceptible to infections.1 A newly diagnosed patient with acute leukemia receives
aggressive chemotherapy treatment and is closely monitored in the hospital for at least 3 to 4
weeks. Treatment-related signs and symptoms including fever, pain, nausea and vomiting, and
respiratory distress may bring the patient to the emergency department before his or her next
scheduled clinic appointment.3,4 In this article a case study of a patient with acute lymphoblastic
leukemia who enters the emergency department will be used to illustrate a common clinical
scenario and provide clinical implications for emergency nurses who care for patients with
hematologic cancers.
Clinical Scenario
A 25-year-old Spanish-speaking Latino man presents in visible distress to the emergency
department with fever, muscle aches, vomiting, coughing, shortness of breath, and a
headache that resolved by the time he arrived in the emergency department. It has been 10
days since his discharge from induction (initial) chemotherapy for precursor B-cell acute
lymphoblastic leukemia. His medical history includes type 2 diabetes and 2 finger
amputations from a work-related injury. His current medications are Bactrim and insulin.
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His vital signs are as follows: temperature, 38.6°C (101.4°F); respirations, 22 breaths/min;
heart rate, 104 beats/min; blood pressure, 98/64 mm Hg; and oxygen saturation, 93% on
room air. Blood was drawn for laboratory testing from his implanted central venous access
device. His white blood cell count was 1.1103/μL; absolute neutrophil count (ANC), 0.3
cells/μ; hemoglobin level, 7.1g/dL; hematocrit level, 23.1%; platelet count, 17,000×103/μL;
and glucose level, 50mg/dL.
Management of Patient With Acute Leukemia
NEUTROPENIA
What is an ANC? An ANC provides the medical team an estimate of the person’s ability to
fight off infections, particularly bacterial infections. A neutrophil is a type of white blood
cell that kills bacteria. The Figure provides step-by-step instructions for calculating the
ANC. An ANC at or below 500 indicates that a patient is at severe risk for infection. An
ANC of 500 to 1000 denotes moderate infection risk, an ANC of 1000 to 1500 indicates
minimal infection risk, and an ANC greater than 1500 is considered not clinically
significant.5
FEBRILE NEUTROPENIA
Febrile neutropenia (FN) is a relatively common but serious complication of treatment and
post-treatment side effects for hematologic cancer patients.6 FN is defined as a single oral
temperature of 38.3°C (101°F) or greater or a sustained temperature of 38.0°C (100.4°F) or
greater over a 1-hour period in combination with neutropenia.7
BLOOD CULTURES
To optimize survival, the source of infection must be determined, and this is done by
obtaining blood cultures. Blood cultures are obtained from the patient’s central venous
access device (ie, Port-a-Cath [Smiths Medical MD, Inc, St. Paul, MN] or peripherally
inserted central catheter) and a peripheral draw to determine the location of infection. In
addition, urine, stool, mouth, skin, and sputum cultures may be obtained to rule out other
sources of infection. A 2-view chest radiograph is typically ordered to rule out respiratory
infections such as pneumonia.
INITIATION OF ANTIBIOTIC THERAPY
The American Society of Clinical Oncology (ASCO) revised its evidence-based practice
guidelines for the management of FN in adults with cancer.8 ASCO still recommends that
patients with neutropenia in whom a fever develops go immediately to the physician’s
office, outpatient clinic, or hospital to receive initial antibacterial treatment.8,9 Evidence-
based guidelines support that early, empirical broad-spectrum antibiotic therapy be initiated
within 1 hour after a fever or blood cultures have been obtained to treat infection. Current
practice guidelines recommend not delaying antibiotic therapy while waiting for blood
culture results unless advised by the physician or health care provider. The patient’s drug
allergies should be known before one selects and administers antibiotic therapy.
Bryant et al. Page 2























The patient described earlier has 3 symptoms that make the clinician suspect sepsis, one of
the gravest dangers to patients with hematologic cancers. In this case fever, mild
hypotension, and tachycardia are observed as the 3 symptoms requiring medical attention.
Early goal-directed therapy for patients with acute leukemia includes fluid resuscitation (to
counter hypotension and tachycardia) and early administration of antimicrobial agents (to
combat infection).10 These interventions have been proven to decrease the mortality rate and
to be cost-effective in a wide variety of situations.11 Although a full complement of goal-
directed therapy services may require more intensive care, these 2 crucial components can
begin while the patient is in the emergency department.
Another important consideration for a patient receiving care for potential sepsis is blood
glucose management. The patient in this case had a blood glucose level of 50 mg/dL, which
was managed with 5% dextrose intravenously and oral intake of food and fluids. The follow-
up blood glucose level was 142 mg/dL after these interventions. Current literature suggests
that monitoring and management per current guidelines play important roles in sepsis care to
optimize survival.12,13 Blood glucose levels in patients should be monitored per hospital-
specific guidelines.
BLOOD TRANSFUSION SUPPORT
Patients with hematologic cancers will also likely need blood products throughout their
treatment. Underproduction of blood and platelets in their marrow and chemotherapy
toxicity are responsible for the inadequate recovery of their blood cells. Given this patient’s
complete blood count values, he will need a transfusion of packed red blood cells. In this
case the transfusion will also help with hypotension and tachycardia, as well as the patient’s
shortness of breath. Although institutional policies vary, it is common to perform a
transfusion in a patient whose hematocrit level is less than 25% or whose platelet count is
less than 20,000.14 Again, institutional practice varies but premedication with 650 mg of
acetaminophen and 25 mg of diphenhydramine orally is commonly used to prevent
transfusion reactions. It is standard of care for a patient with a hematologic cancer to receive
leukocyte-reduced and irradiated blood products to reduce transfusion reactions.
Educating Patient and Caregiver on Protective Precautions
The Oncology Nursing Society recommends the inclusion of the following protective
precautions for neutropenic patients: hand hygiene; protective gowns for expected body
fluid contamination; no visitors with symptoms of respiratory infection; private rooms with
windows closed; negative-pressure rooms with anterooms for patients with airborne
respiratory infections (eg, meningitis or pneumonia); high-efficiency particulate air filters;
contact precautions with resistant organism colonization; and guidelines for the handling of
ice, flowers, plants, and animals.15 Because the presented patient was accompanied by a
close family member to the emergency department, it is important to communicate these
precautions to both the patient and caregiver. Standardized patient education improves
caregivers’ overall well-being and should become a routine part of patient care.16
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Identification and Management of Cancer-Related Distress
The highest priority in care for patients with hematologic cancers in the emergency
department is providing fluid resuscitation, antibiotics, and blood products as needed.
However, once stabilization has begun, patients’ cancer-related distress (CRD) should be
addressed to optimize their long-term outcomes. CRD is a complex psychological
phenomena that has been found in as many as 35% to 50% of patients with hematologic
cancers.17,18 Current theory suggests that demographics, intrinsic factors (personality),
social support, disease progression, treatment, and communication with the health care team
are all pre-existing factors that may contribute to CRD.19 Patients may be more vulnerable
to CRD at various points in the treatment trajectory, which can include visits to the
emergency department.
Although CRD is prevalent, it is often unrecognized in patients with cancer including
hematologic cancer.20 High levels of CRD are associated with increased symptoms and
lengths of hospitalization, as well as decreased health-related quality of life, and may
necessitate modifications in chemotherapy treatment.21 FN, a severe side effect in patients
receiving aggressive chemotherapy treatment, has been found to increase the symptom
severity that patients experience and often delays chemotherapy treatment.22 Therefore
patients in whom FN develops are at an additional risk of having CRD that may further
complicate their care.
Recently, there has been a call for health care providers to recognize distress as the sixth
vital sign, given the health and financial consequences associated with its presence.23 Thus
nurses play a critical role in identifying and managing patients who are having CRD. The
assessment of CRD may include using an instrument such as the National Comprehensive
Cancer Network’s Distress Thermometer, which asks patients to rate their level of distress
on a 0 to 10 numeric rating scale. Screening for distress should also include active listening
and the assessment of both verbal and nonverbal cues.24
The management of CRD varies depending on the level of distress reported by the patient.
Patients with moderate to high levels of CRD (defined as ≥4 of 10) should receive a referral
to either a mental health, social work, pastoral care, or palliative care provider, depending on
the source of distress.25 The Table provides further guidance on distress management and
common symptoms based on varying levels of distress. Emergency nurses who assess CRD
can help to manage this by using therapeutic communication skills that promote a trusting
relationship23 and allow adequate time for the patient to ask questions and understand the
plan of care.24 Nursing care is imperative in the identification and management of CRD and
can lead to positive outcomes for patients and their families, which ultimately improves
health-related quality of life and quality of care.
Conclusion
The described patient entered the emergency department because of physical and CRD
changes and was admitted to the hospital. Per ASCO guidelines regarding management of
FN, he was appropriately assessed, blood cultures were obtained, he received antibiotic
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treatment for FN and supportive care provided through fluid and blood transfusions, and
cancer care education was provided to the patient and his caregiver. Emergency nurses will
encounter such patients presenting with delayed and late side effects from treatment. The
recognition of immunosuppression as a risk factor for sepsis is especially important. To
optimize survival, these patients need to be admitted to the hospital for observation and
antibiotic therapy while their blood cultures are pending, rather than being treated and
discharged from the emergency department. By advocating for evidence-based care and
identifying CRD, emergency nurses are critical in ensuring that patients with FN receive
early medical intervention.
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Step-by-step instructions for calculating ANC.
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TABLE
Levels of distress, management, and common symptoms15,23
Level of distress Management Common symptoms of distress that
may be observed in emergency
department
Low (0–3 of 10) • Develop strong communication style to facilitate
development of trusting relationship
• Validate patient’s feelings
• Provide list of resources as appropriate






• Follow same steps for low level of distress
• Provide appropriate referral based on source of distress to
social work, pastoral care, psychology, and palliative care
providers
Somatic: gastrointestinal upset, pain,
dyspnea, palpitations, fatigue,
weakness
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